Still think we're going to retrace to .145? I don't see it going that far down honestly. I also, don't think the buying is based on any anticipation of rapimeds. This is all based on the latest quarter report, future revenues from compounding etc. Profitability!!! Crazy potential!!! The word is getting out there.